July 26, 2021
In January 2020, Marco Lobba had developed a new way of fusing proteins together that he thought could help treat autoimmune diseases like lupus, multiple sclerosis or Type 1 diabetes. A year later, he and Geo Guillen remotely launched Catena Biosciences, turning the potentially lifesaving idea into a successful company.
July 21, 2021
Chemical biologists in the Wenjun Zhang Lab at the University of California, Berkeley, have discovered compound mutanofactin-697. This compound is crucial in the development of cavities induced by Streptococcus mutans and may serve as a target in the prevention and treatment of dental caries.
June 24, 2021
QB3-Berkeley affiliate and public health expert Lee Riley addresses state reopening plans, the effectiveness of the COVID-19 vaccine against variants, health inequities that have been exposed by the pandemic, and moving forward to “a new type of normal.”
June 24, 2021
UC Berkeley celebrates the retirement of Harry Stark after 18 years as director of facilities and engineering for the Vice Chancellor for Research.
June 23, 2021
The SARS-CoV-2 virus contains a gene that codes for a strange protein that could be a good target for drugs to fight COVID-19 and possibly other coronavirus infections, according to a new study from the University of California, Berkeley.
June 02, 2021
Postdoctoral scholar Briana Van Treeck examines how scientists are exploiting the unique abilities of an enzyme to increase throughput and decrease bias in RNA sequencing.
June 01, 2021
Most of us will never win a Nobel Prize, but the University of California, Berkeley, is offering everyone the opportunity to purchase the next best thing: nonfungible tokens (NFTs) for the patent disclosures at the heart of two Nobel Prize-winning inventions from the university’s research labs.
May 19, 2021
Paul Lum, the managing director of the Biomolecular Nanotechnology Center (BNC), talks about the history of the facility, its unique equipment, and the BNC’s research and culture.